Paradoxical vagal tachycardia in ganglion-blocked anesthetized dogs.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000758:Anesthesia; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001949:Bretylium Compounds / Q000494:pharmacology; D002714:Chlorisondamine / Q000494:pharmacology; D003647:Debrisoquin / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D004285:Dogs; D004347:Drug Interactions; D004558:Electric Stimulation; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006145:Guanethidine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D008774:Methylphenidate / Q000494:pharmacology; D010096:Oxprenolol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D014630:Vagus Nerve / Q000502:physiology*
D000319:Adrenergic beta-Antagonists; D001949:Bretylium Compounds; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D008774:Methylphenidate; D010096:Oxprenolol; D008464:Mecamylamine; D001285:Atropine; D012110:Reserpine; D002714:Chlorisondamine; D003891:Desipramine; D003647:Debrisoquin; D006145:Guanethidine